Venous or arterial samples for activated clotting time measurements: a systematic review

被引:1
|
作者
Iddawela, Sashini [1 ]
Swamy, Priti [2 ]
Member, Sajid [3 ]
Harky, Amer [4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Birmingham, Dept Resp Med, Birmingham, W Midlands, England
[2] Kings Coll London, GKT Sch Med Educ, London, England
[3] Univ Cent Lancashire, Lancashire Sch Med & Dent, Greenbank Bldg, Preston, Lancs, England
[4] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[5] Univ Liverpool, Fac Hlth & Iife Sci, Dept Integrat Biol, Liverpool, Merseyside, England
[6] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[7] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[8] Alder Hey Children Hosp, Dept Cardiac Surg, Liverpool, Merseyside, England
来源
PERFUSION-UK | 2021年 / 36卷 / 08期
关键词
clotting factors; ACT; venous; arterial; cardiac surgery; cardiac catheterisation; COAGULATION TIME; HEPARIN; THROMBOELASTOGRAPHY; SURGERY;
D O I
10.1177/0267659120967836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The systematic review aims to investigate the effect of sampling source on activated clotting time (ACT) measurement within cardiovascular surgery and cardiac catheterisation. It also examines the evidence surrounding novel clot assessment techniques and associated sampling variation. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar until 20th June 2020. All studies reporting sampling source variability of ACT in cardiac surgery, vascular surgery and cardiac catheterisation were included. Results: Fourteen studies were included in the systematic review. Inconsistent reports of variability were seen in cardiac surgery and cardiac catheterisation. There were no studies directly examining ACT variability in vascular surgery. Novel clot assessment techniques have been validated in cardiac surgery, but measurements vary depending on sampling source. Conclusion: Sampling source should be kept consistent to facilitate effective haemostatic strategies. More research is needed regarding variability in vascular surgery and novel clot assessment techniques.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 50 条
  • [21] Activated Clotting Time as a Marker of Inflammation in Hospitalized Patients
    Papageorgiou, Christos
    Synetos, Andreas
    Tampakis, Konstantinos
    Anninos, Hector
    Kontogiannis, Christos
    Kapelouzou, Alkistis
    Kanakakis, Ioannis
    Tousoulis, Dimitrios
    Paraskevaidis, Ioannis
    Toutouzas, Konstantinos
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [22] An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model
    Berk, Zachary B. K.
    Shah, Aakash
    Sun, Wenji
    Griffith, Bartley P.
    Wu, Zhongjun J.
    ARTIFICIAL ORGANS, 2022, 46 (03) : 501 - 505
  • [23] Correlations Between Activated Clotting Time Values and Heparin Concentration Measurements in Young Infants Undergoing Cardiopulmonary Bypass
    Guzzetta, Nina A.
    Monitz, Heather G.
    Fernandez, Janet D.
    Fazlollah, Tom M.
    Knezevic, Andrea
    Miller, Bruce E.
    ANESTHESIA AND ANALGESIA, 2010, 111 (01): : 173 - 179
  • [24] The Activated Clotting Time Paradox Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures
    Pacchioni, Andrea
    Ferro, Jayme
    Pesarini, Gabriele
    Mantovani, Riccardo
    Mugnolo, Antonio
    Bellamoli, Michele
    Penzo, Carlo
    Marchese, Giuseppe
    Benedetto, Daniela
    Turri, Riccardo
    Fede, Alfredo
    Benfari, Giovanni
    Sacca, Salvatore
    Ribichini, Flavio
    Versaci, Francesco
    Reimers, Bernhard
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (09)
  • [25] The relationship between heparin level and activated clotting time in the adult cardiac surgery population
    FitzGerald, D. J.
    Patel, A.
    Body, S. C.
    Garvin, S.
    PERFUSION-UK, 2009, 24 (02): : 93 - 96
  • [26] Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
    Heemelaar, J. C.
    Berkhout, T.
    Heestermans, A. A. C. M.
    Zant, J. C.
    de Vos, A. M. J.
    Verouden, N. J. W.
    Dirksen, M. T.
    van Ramshorst, J.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2021, 2021
  • [27] USE OF THE ACTIVATED CLOTTING TIME IN ANTICOAGULATION MONITORING OF INTRAVASCULAR PROCEDURES
    BOWERS, J
    FERGUSON, JJ
    TEXAS HEART INSTITUTE JOURNAL, 1993, 20 (04) : 258 - 263
  • [28] Mixed venous and arterial blood in bovine coccygeal vessel samples for blood gas analysis
    Tvedten, H
    Kopcia, M
    Haines, C
    VETERINARY CLINICAL PATHOLOGY, 2000, 29 (01) : 4 - 6
  • [29] Comparative analysis of haematological, haemostatic, and inflammatory parameters in canine venous and arterial blood samples
    Lue, Anne Palsgaard-Van
    Jensen, Asger Lundorff
    Strom, Henriette
    Kristensen, Annemarie T.
    VETERINARY JOURNAL, 2007, 173 (03): : 664 - 668
  • [30] Variability of Activated Clotting Time by Site of Sample Draw During Percutaneous Coronary Intervention: A Prospective Single-Center Study
    Morris, Jacqueline H.
    Lee, Junsoo Alex
    McNitt, Scott
    Goldenberg, Ilan
    Narins, Craig R.
    ANGIOLOGY, 2021, 72 (07) : 673 - 678